Are you Dr. Wittkamp?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
7001 Forest Ave
Ste 200
Richmond, VA 23230Phone+1 804-288-3123Fax+1 804-282-3322
Summary
- Dr. Michael Wittkamp, MD is a cardiologist in Richmond, Virginia. He is currently licensed to practice medicine in Virginia and North Carolina. He is affiliated with Bon Secours Memorial Regional Medical Center.
Education & Training
- Virginia Commonwealth University Health SystemFellowship, Interventional Cardiology, 2005 - 2006
- Virginia Commonwealth University Health SystemFellowship, Cardiovascular Disease, 2002 - 2005
- Virginia Commonwealth University School of MedicineClass of 1999
Certifications & Licensure
- VA State Medical License 1999 - 2024
- NC State Medical License 2006 - 2008
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 8 citationsSafety of drug-eluting stents in patients with left ventricular dysfunction undergoing percutaneous coronary intervention.Annunziata Nusca, Michael J. Lipinski, Amit Varma, Darryn L. Appleton, Evelyne Goudreau
The American Journal of Cardiology. 2008-09-15 - 79 citationsVardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial KATP channels...Fadi N Salloum, Ramzi A Ockaili, Michael Wittkamp, Vijay R. Marwaha, Rakesh C. Kukreja
Journal of Molecular and Cellular Cardiology. 2006-03-01 - 157 citationsPharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications.Rakesh C. Kukreja, Fadi N Salloum, Anindita Das, Ramzi A Ockaili, Chang Yin
Vascular Pharmacology. 2005-04-01
Professional Memberships
- Member